Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biotechnology Visionary Joins Stratos Group; Dr. Mark Stolowitz Brings Biotech Insight and Expertise to Product Development Firm.


Business Editors/Health/Medical Writers

SEATTLE--(BUSINESS WIRE)--Oct. 22, 2003

Stratos Product Development LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
, a full-service product development firm with comprehensive in-house design, engineering, marketing, and incubation capabilities, today announced the appointment of Mark L. Stolowitz, Ph.D. as Vice President and Chief Science Officer.

Dr. Stolowitz has been an emerging life science technologies expert for more than 20 years. He was the founding President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Prolinx, and the inventor of their proprietary chemical affinity In physical chemistry, chemical affinity, historically, refers to the "force" that causes chemical reactions.[1] A broad definition, used generally throughout history, is that chemical affinity is that whereby substances enter into or resist decomposition.  technology. Prior to founding Prolinx, Dr. Stolowitz was the Protein Microsequencing Group Leader under Prof. Leroy Hood Leroy Hood is an American biologist. He won the 2003 Lemelson-MIT Prize for inventing "four instruments that have unlocked much of the mystery of human biology" by helping decode the genome.  at the California Institute of Technology California Institute of Technology, at Pasadena, Calif.; originally for men, became coeducational in 1970; founded 1891 as Throop Polytechnic Institute; called Throop College of Technology, 1913–20. .

"Dr. Stolowitz's exposure to the latest research in molecular biotechnology gives us insight that is rather extraordinary for a product development firm," said Al Stephan, chief executive officer at Stratos. "The depth of knowledge and experience he brings to the table adds invaluable experience to our internal teams, Stratos' clients and our incubation companies."

He is a frequently published author and is the recipient of 38 United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  Patents in the areas of biosensor A device that detects and analyzes body movement, temperature or fluids and turns it into an electronic signal. See lab on a chip and data glove.
Biosensor 
 design, chemical affinity technologies, separation science, surface engineering, and protein sequencing.

"Stratos is in a unique position," said Dr. Stolowitz, "Not only do the scientists, bioengineers and experienced product designers provide a collaborative environment where biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 companies can bring their product development challenges, but the think-tank atmosphere and entrepreneurial spirit of the executive team allows for incubation and acquisition opportunities for the company."

About Stratos

Stratos (www.stratos.com) is a full-service product development firm with comprehensive design, engineering, marketing, program management, product positioning and incubation capabilities all under one roof. With a team of 40 industrial designers, mechanical, electrical, software, optical, and biomedical engineers, project managers, marketing experts and business strategists who have an average of 15 years professional experience, Stratos is dedicated to bridging the gap between innovation, function and the best possible ROI (Return On Investment) The monetary benefits derived from having spent money on developing or revising a system. In the IT world, there are more ways to compute ROI than Carter has liver pills (and for those of you who never heard of that expression, it means a lot).  for clients. Stratos' size and experience allow for execution of every phase of product development, from planning to finished result.

Stratos is committed to the formation of successful companies from innovative ideas. The firm encourages the growth of emerging technologies and has incubated a number of companies by providing everything from facilities to funding to staffing to marketing support.

Headquartered in downtown Seattle, Stratos Product Development LLC is located at 2025 First Avenue, Market Place Tower, Suite PH-B Seattle, WA 98121 and can be reached by phone at 206-448-1388. More information is available at www.stratos.com.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 22, 2003
Words:408
Previous Article:J.D. Power and Associates Reports: Rising Premiums Are Not Impacting Homeowners Insurance Customer Satisfaction.
Next Article:Insignia Solutions to Host Webcast to Discuss Third Quarter 2003 Financial Results.



Related Articles
Stratos Forms Alliance with Micronics; Companies Offer Combined Capabilities from Technological Innovation to Commercial Product Launch.
SUPER POWER WHILE OTHER BUSINESSES LANGUISH IN ECONOMIC DOLDRUMS, BIOTECH FIRMS OFFER ONE BRIGHT, SHINING LIGHT FOR INVESTORS, POTENTIAL WORKERS.
Craig Shaffer Joins Rosa as VP of Services.
Miikana Therapeutics Inc. Raises $4.25 Million in Series a Financing; Company Applies a Clinically Driven Approach to Oncology Drug Development.
Three Life Science Pioneers to Speak at Biotech 2004.
Silicon Valley Expert Witness Group Names Dr. Paul Newton as Director of Biotechnology Expert Witness Services.
Accelerator Corporation Adds $11.8 Million and Two New Investors; Amgen Ventures and OVP Join Other Life Science Leaders to Fund Biotech Start-Ups.
Pursuing biotechnology: opportunities abound for innovative entrepreneurs in this multibillion-dollar industry.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles